Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(33%)
Results Posted
75%(3 trials)

Phase Distribution

Ph phase_1
1
17%
Ph phase_2
1
17%
Ph phase_3
3
50%
Ph phase_4
1
17%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
3(50.0%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(4)

Detailed Status

Completed4
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 33 (50.0%)
Phase 41 (16.7%)

Trials by Status

completed467%
recruiting117%
active_not_recruiting117%

Recent Activity

2 active trials
Showing 5 of 6
recruitingphase_1

Novel Approaches for Improving Vascular Function in Veterans With HFpEF

NCT06312748
active_not_recruitingphase_4

A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)

NCT02099123
completedphase_3

Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)

NCT03768427
completedphase_3

Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)

NCT03867318
completedphase_3

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins

NCT02135029
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06312748Phase 1

Novel Approaches for Improving Vascular Function in Veterans With HFpEF

Recruiting
NCT02099123Phase 4

A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)

Active Not Recruiting
NCT03768427Phase 3

Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)

Completed
NCT03867318Phase 3

Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)

Completed
NCT02135029Phase 3

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins

Completed
NCT01288469Phase 2

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6